ABSTRACT -Wormwood , Artemisia absinthium, is a very bitter plant, and its extract has been used as food additives such as seasonings for food and drinks. A 13-week repeated dose toxicity study of wormwood extract was performed in both sexes of Wistar Hannover (GALAS) rats. Rats were divided into 4 groups consisting of 10 males and 10 females each, and were given water containing 0, 0.125, 0.5, or 2% wormwood extract. All rats had survived at the end of the study, and no changes indicating obvious toxicities that are attributable to the treatment of wormwood extract were observed in the body weights, hematological and serum biochemical examinations, organ weights, and histopathological examinations. Based on the results of the present study, the NOAEL (no-observed-adverse-effect-level) of wormwood extract of Wistar Hannover rats was estimated to be 2% (equivalent to 1.27 g/kg/day in males and 2.06 g/kg/day in females) or more.
INTRODUCTION
Wormwood extract is extracted from an Asteraceous plant belonging to the composite family, Artemisia absinthium, by ethanol and its main component is sesquiterpene such as absinthen (John et al., 1999; Olsen, 2000) . Wormwood had been recommended as a stomach medicine useful for gastric pain, a cardiac stimulant, a restorative of declining mental functions and so on in Western European traditional herbal medicine systems for long time, but was banned in France since 1915 because too much of it caused incurable damage to the nervous system (Grieve, 1931) . As other pharmacological effects, wormwood extract has been reported to exhibit anti-inflammatory and antipyretic effects, since this plant contains azulenes (Ikramet et al., 1985) . In addition, protective effects of this extract have been experimentally demonstrated on hepatic damage Ryu et al., 1998; Park et al., 2000) and gastric damage in rats (Gharzouli et al., 1999) . Today, wormwood extract has been added to beer, tea, and coffee as representative bitter taste seasonings in food additives (Grieve, 1931; Brown, 1984; Chevallier, 1996) , and has also been used in Japan. Meanwhile, thujone that is also contained in wormwood has a chemical structure resembling that of delta 9 tetrahydrocannabinol, an active ingredient of marijuana, and the administration of a high dose of this substance is induced to act on receptors common in the central nervous system, causing recidivism, hallucination, derangement, and convulsion in humans (John et al., 1999; Olsen, 2000) . However, few studies have been reported on the safety of wormwood extract as a food additive, in spite of its long history of use. Therefore, in the present study, as a part of a comprehensive safety evaluation of food additives by the Japanese Ministry of Health, Labor and Welfare, a 13-week repeated dose toxicity study of wormwood extract was performed in rats.
MATERIALS AND METHODS

Test chemical and dose level
The wormwood extract was kindly supplied by
Correspondence: Tomoko MUTO San-Ei Gen F.F.I. Co., Ltd. (Osaka, Japan).This extract is the mixture of unknown substances including α and β thujone that has been reported to have a neurotoxic action (John et al., 1999; Olsen, 2000) . The concentration of α thujone that is more toxic in the wormwood extract has been reported to be 0.53 to 1.22% (Lawrence, 1995) . The present 13-week study was performed in accordance with the guideline on 13-week repeated toxicity studies that was recommended by the Japanese Ministry of Health, Labor and Welfare. It has been recommended in this guideline that feeding studies or studies of drinking water should be performed in repeated dose toxicity studies for food additives. Prior to the 13-week toxicity study of the wormwood extract, as a preliminary study, three male and three female rats were given water containing 5, 2, or 1% wormwood extract for 7 days to examine the unpalatability of the test substance in rats. Rats of the 5% group rejected drinking the test water, and there were marked differences in the ratio of body weight gain and food consumption between this group and the control group. In the 2% group, slight rejection of drinking water was observed in a few rats, but there was no marked difference in the ratio of body weight gain between the 2% group and the control group. No clinical signs attributable to the treatment of the test substance were observed in any of the treated groups. Therefore, the dose of 2% was set as the highest dose of the 13-week study, and the doses of 0.5% and 0.125% (common ratio: 1/4) were set as the middle and low doses, respectively.
Animals and experimental design
Forty male and 40 female 5-week-old Wistar Hannover (GALAS) rats were purchased from CLEA Japan Co., Ltd. (Kanagawa, Japan), and acclimated for about 1 week. Male and female rats were then divided into 4 groups of 10 animals each, and were housed in a room maintained under the following conditions: 12-hr light/ 12-hr dark cycle at 24 ± 2°C, and 55 ± 10% relative humidity. Two or 3 rats/cage were housed together, and a commercial pellet diet (CE-2, CLEA Japan Co., Ltd.) was given ad libitum. All experimental procedures were conducted following approval of the Committee on Animal Care and Use in Tokyo University of Agriculture and Technology.
The test substance was stored at 4°C until preparation, and the preparation of the test water was performed twice or 3 times a week. Clinical signs and general appearance were observed once a day and body weights as well as food and water consumption were measured once a week. Thirteen weeks after the treatment, all rats were sacrificed and autopsied.
Under ether anesthesia, laparotomy was performed. Blood was collected through the abdominal aorta. The hematological examination was performed using an automatic multichannel blood cell counter (Sysmex type SE-9000, Sysmex). The parameters included red blood cell count (RBC), hemoglobin (HB) level, hematocrit value (HT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), and white blood cell count (WBC). The blood cells were classified into the following 4 items using an automatic blood cell analyzer (MICROX HEG-120A, Tateishi Electric): segmented neutrophils (SEG), eosinophils (EOS), lymphocytes (LYMPH), and monocytes (MONO). Furthermore, a serum biochemical examination was performed at SRL Co., Ltd. (Tokyo, Japan), and the following parameters were measured: total protein (TP), albumin/globulin ratio (A/G), total cholesterol (TC), blood urea nitrogen (BUN), creatinine (CRE), calcium (Ca), inorganic phosphorus (IP), sodium (Na), potassium (K), chlorine (Cl), aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and albumin (ALB). At autopsy, the brain, heart, lungs, liver, kidneys, spleen, thymus, pituitary gland, adrenal gland, thyroid gland, submandibular gland, testis, uterus, and ovary were weighed. In addition to the earlier mentioned organs, the cranium with nasal cavity, pituitary, eyeballs, Harderain glands, spinal cord, stomach, small and large intestine, pancreas, urinary bladder, skin, mammary gland, mesenteric lymph nodes, trachea, esophagus, tongue, skeletal muscle, sciatic nerve, epididymis, seminal vesicles, prostates and vagina were fixed in 10% neutral buffered formalin and cut into thin sections according to the standard method for hematoxylin and eosin staining. Histopathological examinations were carried out only on the 2% and control groups of both sexes.
Statistical analysis
With respect to the body weight, food consumption, water consumption, hematological parameters, serum biochemical parameters, and organ weights, the means and standard deviation were calculated in each group and a multiple comparison test was used. Briefly, the homogeneity of variance was investigated using Bartletts test. When no significant heterogeneity was detected, Dunnetts test was performed (Dunnett, 1955) . When significant heterogeneity of variance was detected, Dunnetts type rank sum test was performed. A p-value less than 0.05 was considered statistically significant in this analysis.
RESULTS
During the experimental period, no animal died. Changes in body weight gain in treated groups during the experimental period were similar to those in the control group of both sexes (Fig. 1, Table 1 ). There were no significant differences in water and food consumption between the treated and control group during the experimental period (Table 1) .
Hematological examinations showed a significant increase in the ratio of MONO in the differential blood count in males of the 0.5% group (Table 2 ). In females, there were no hematological changes that are related to the substance. Serum biochemical examinations showed significant increases in TP, ALB, BUN, Na, and Cl levels in males of the 2% group (Table 3) . In females of the 0.5% and 2% groups, the A/G ratio was significantly reduced. Females of the 0.5% group also showed a significant increase of the CRE level.
There were no significant changes of the absolute organ weights between the treated and control groups. In the 2% groups of both sexes, the relative liver weight was significantly increased as compared to the control (Table 4) .
In histopathological examinations, males of the 2% group had microgranulomas of the liver, basophilic tubules/calcification of the kidney, focal myocardial necrosis, intra-alveolar hemorrhage, cerebral calcification, vacuolation of serous acini in the submandibular gland, aggregation of mononuclear cells in the prostate, cyst/cellular hypertrophy in the pituitary pars distalis, a cyst-like structure in the pituitary pars intermedia, and hypertrophy of the thyroid gland (Table  5 ). In females of the 2% group, microgranulomas of the liver, basophilic tubules/hyaline cast/calcification of the kidney, cerebral calcification, vacuolation of serous acini in the submandibular gland, pituitary Rathke's pouch, cysts in the pituitary pars distalis, and pituitary cyst-like structures in the pituitary pars intermedia were observed (Table 5 ). There were no significant differences in the incidences of these changes between the 2% and control groups.
DISCUSSION
Absinthe was a popular drug of abuse that was commonly used in Italy, France and Switzerland in the late 1800s and early 1900s. Analysis of absinthe revealed that the essential oil extracted from the wormwood, Artemisia absinthium, was the active plant product, and that thujone was the CNS-active component in the oil of wormwood (Arnold, 1988) . Because absinthe appeared to constitute an epidemic health problem, the distribution of absinthe was banned in many countries (Vogt and Montagne, 1982) . In 1975, Del Castillo et al. (1975) reported a structural similarity between thujone and delta 9 tetrahydrocannabinol, the active component in marijuana, and speculated that thujone and delta 9 tetrahydrocannabinol bound to the same receptor, the cannabinoid receptor, in the brain that was responsible for marijuana intoxication. However, the wormwood extract has been demonstrated to exhibit low affinity for the cannabinoid receptor (Meschler and Howlett, 1999) . Therefore, the toxic mechanism of action of the wormwood extract has not been elucidated until now (Olsen, 2000) . Moreover, although the wormwood extract has been used in Western herbal medicines for a long time Ryu et al., 1998; Gharzouli et al., 1999; Park et al., 2000) , the mechanisms of action on the pharmacological effects of the wormwood extract are still unknown, and few studies have been reported on the safety of the wormwood extract to consumers as a food additive. As a part of a comprehensive safety evaluation of food additives in the Japanese Ministry of Health, Labor and Welfare, a 13-week repeated dose toxicity study of the wormwood extract was performed in rats.
In hematological examinations, the ratio of Table 3 . Data of serum biochemical examination in rats given water containing wormwood extract for 13 weeks. .8 ± 0.6 6.6 ± 0.6 6.6 ± 0.3 7.0 ± 0.5 A/G 2.7 ± 0.4 2.3 ± 0.3 2.3 ± 0.4 * 2.2 ± 0.3 * TC mg/dl 57.6 ± 10.7 48.4 ± 7.0 49.9 ± 9.4 55.6 ± 11.7 BUN mg/dl 23.2 ± 2.0 22.6 ± 3.1 22.3 ± 3.0 23.3 ± 3.2 CRE mg/dl 0.31 ± 0.02 0.30 ± 0.04 0.27 ± 0.02 * 0.29 ± 0.04 Ca mg/dl 10.1 ± 0.5 9.9 ± 0.5 10.0 ± 0.4 10.5 ± 0.4 IP mg/dl 4.5 ± 0.6 4.4 ± 0.9 4.8 ± 0.4 4.6 ± 0.6 Na mEQ/l 145.9 ± 1.5 146.8 ± 1.8 146.2 ± 2.1 145.4 ± 1.1 K mEQ/l 3.1 ± 0.3 3.2 ± 0.4 3.1 ± 0.3 3.0 ± 0.3 Cl mU/dl 105.9 ± 1.9 107.3 ± 2.9 105.9 ± 0.9 104.7 ± 2.0 AST IU/l 79.4 ± 18.3 70.5 ± 15.4 69.7 ± 9.5 73.9 ± 24.9 ALT IU/l 44.1 ± 14.6 38.9 ± 10.8 40.4 ± 8.9 51.0 ± 26.4 ALP IU/l 148.8 ± 23.0 183.2 ± 88.8 203.6 ± 88.7 145.7 ± 67.2 ALB g/dl 4.9 ± 0.4 4.6 ± 0.4 4.6 ± 0.4 4.8 ± 0.5 a) : Mean ± S.D. * : Significantly different from the control at p<0.05. ** : Significantly different from the control at p<0.01. MONO in the differential blood count was significantly increased in males of the 0.5% group, but it was not observed in other treated groups and considered to be a incidental finding. In serum biochemical examinations, TP, ALB, BUN, Na, and Cl levels were significantly increased in males of the 2% group. The A/G ratio was reduced in females of the groups receiving 0.5% or more. As these alterations were very small in their fluctuation range and there were no changes in other related parameters, these changes were considered to be of no toxicological significance. Moreover, the decreased serum level of CRE observed in females of the 0.5% group was regarded as an incidental finding, because such a change was not observed in the highest dose group.
Relative liver weights were significantly increased in both sexes of the 2% group. However, since there were no increases in their absolute weights in this group, and no histopathological treatmentrelated changes were observed in the liver, these changes cannot be interpreted as meaningful toxicological effects. Vacuolated degeneration of serous acini in the submandibular gland was observed in males and females of the 2% and control groups, but this change in moderate degree was seen in 2 males of the 2% group, in comparison with the slight changes in the control group. However, there was no significant difference in the incidence of this change between the An increased lethality (60% in females and 37% in males) was shown in rats that were orally given 50 mg/kg bw/day of thujone for 13 weeks (European Commission, 2003) . In this experiment, convulsions were observed in the sub-dose (25 mg/kg/day), but no neurological signs were observed in the lowest dose (12.5 mg/kg/day). In addition, it has also been reported that the administration of a high dose of thujone induced recidivism, hallucination, derangement, and convulsion in humans (John et al., 1999; Olsen, 2000) . In our preliminary 7-day repeated dose study in rats, rats were given water containing 5, 2, or 1% wormwood extract. However, no neurological signs were observed in rats of the 5% group, although the highest dose rats rejected drinking the test water and marked differences in the ratio of body weight gain and food consumption were detected between this group and the control group. Because of the unpalatability of the test substance in the 5% group, the dose of 2% was set as the highest dose in the present 13-week study. The finding that there was no neurological sign in the 2% group in the present study suggests that such a high dose of thujone inducing neurological signs is not contained in 2% wormwood extract. In other words, it can be said that the possibility of the induction of neurotoxic effects of thujone is extremely low by the inges- tion of up to 2% wormwood extract.
In conclusion, there were no toxic changes related to the administration of the wormwood extract in the groups given 2% wormwood extract, and the NOAEL (no-observed-adverse-effect-level) of the wormwood extract in Wistar Hannover rats was estimated to be 2% (equivalent to 1.27 g/kg/day in males and 2.06 g/kg/day in females) or more. This report is the first investigation concerning the subchronic oral toxicity of the wormwood extract in rats, and studies on the chronic toxicity and carcinogenicity of the wormwood extract have not been performed yet. Further studies addressing chronic toxicity and carcinogenicity are necessary to estimate the Acceptable Daily Intake (ADI ) for consumers of this extract.
